Samuel W. French
Papers
1
Total Citations
17
H-Index
1
About
Samuel W. French is a nuclear medicine and molecular imaging researcher whose work centers on the application of novel PET radiotracers for oncologic staging and the characterization of incidental findings. His most-cited study, published in *Clinical Nuclear Medicine*, investigates the incidental detection of elastofibroma dorsi using both 68Ga-FAPI-46 and 18F-FDG PET/CT in a patient with esophageal cancer, contributing to the growing understanding of fibroblast activation protein (FAP) imaging. This work, part of the prospective trial NCT04147494, has garnered 17 citations and highlights French’s focus on improving diagnostic accuracy through comparative tracer analysis. His research bridges the gap between radiotracer development and clinical decision-making, particularly in esophageal cancer management. By demonstrating how FAPI-avid benign lesions can mimic malignancy, French has helped refine imaging interpretation protocols. His contributions are valuable for students and researchers exploring theranostics, cancer staging, and the nuanced role of PET/CT in differentiating benign from malignant processes.
Research Focus
Key Achievements
Top Papers
- 1